Attitudes of European physicians towards the use of long-acting injectable antipsychotics

BACKGROUND: Prescription rates for long-acting injectable (LAI) antipsychotic formulations remain relatively low in Europe despite improved adherence over alternative oral antipsychotic treatments. This apparent under-prescription of LAI antipsychotics may have multiple contributing factors, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Maxine X., Bent-Ennakhil, Nawal, Sapin, Christophe, di Nicola, Sylvie, Loze, Jean-Yves, Nylander, Anna-Greta, Heres, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071632/
https://www.ncbi.nlm.nih.gov/pubmed/32169077
http://dx.doi.org/10.1186/s12888-020-02530-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071632/
https://www.ncbi.nlm.nih.gov/pubmed/32169077
http://dx.doi.org/10.1186/s12888-020-02530-2

Ejemplares similares